New blood tests can reveal your life expectancy
New blood tests can reveal your life expectancy
Voltor Longo mentioned this new work as being very promising so it likely is a better way to measure biological age. Personally I haven't taken any such test because I haven't found one good and affordable enough - if this gets commercialized it might be the ticket.
OTOH while my health is better than when I was 20, do I really want to know what the biology says? All tests are subject to error, and I don't do measurements unless I know how to mitigate a negative result. I can't do anything beyond what I'm already doing for health, so there's not much point, unless the number comes out fantastic (which I guess it probably would honestly) which would have positive psychological benefits.
-
That's an interesting article, Dan.
Assessments of biological age are very controversial. From my extensive study of the topic, it is very difficult to assess biological age in a way that is scientifically beyond reproach. Several groups are working on making a test panel that is useful for this assessment, but I haven't heard of any remarkable successes yet. Epigentic age (called "Horvath's clock") seems like a promising one. -
Related to Maximus's reply and the article cited by Dan Mc, one of the best article recently read on the subject is the paper by Morgan Levine et al.
Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY). 2018;10(4):573-591.
-
While I fully agree with Maximus about how much controversial is the assessment of biological age (BA) I feel both various epigenetic clocks such as DNAm PhenoAge (see Morgan Levine’s paper I refer to in my previous post) and machine learning/AI driven tools are approaching a good estimation.
However, the nature of aging is such only a real system biology approach will be truly useful (meaning a convergence of all methodologies at different system levels: cell/tissue/organ/organism)
Also keep in mind relative values, meaning changes in time vs. absolute values, are likely more important as they should reflect the effectiveness of our interventions.
The good of DNAm PhenoAge is, IMHO, the good methodology it was used to determine it:
- Training on well-known and well-characterized cohorts,
- Focusing on both morbidity and mortality,
- Robust statistic (penalized Cox regression) to reduce the number of (clinically relevant) biomarkers to a small number then used as weights in the Gomptertz’s mortality curve resulting in a first BA assessment (phenoage),
- Regression of phenoage on DNA methylation sites to sort out 513 CpGs sites. Here a fascinating topic is correlation vs. causation which I do not think is resolved yet,
- Assessment of estimations on well characterized cohorts at each state of the process.
On the machine learning/Ai front, you might also try using very simple AI tool as aging.ai where you can input you blood markers and have a guess of BA.
-
Also, even if more research oriented than strictly in tracking BA, I wonder if someone here knows something along the same lines as the following paper (more systemic) but recent (the paper is from a UK workshop of experts in 2012 !) and with longitudinal tracking:
Lara J, Cooper R, Nissan J, et al. A proposed panel of biomarkers of healthy ageing. BMC Med. 2015;13:222.
-
OK, I now have the results of our LifeExtension blood work done four days ago in preparation for calculating our DNAm PhenoAge from the Levine, et al paper referenced above. The actual calculation is rather formidable, involving lots of exponentials and natural logarithms, so instead of using Excel I wrote a Mathematica notebook to do the evaluation (which is available HERE). The paper provides a procedure for calculating the probability of mortality in the next 10 years and what they call the "DNAm PhenoAge", which is based on this 10-year mortality probability. My wife and I had these blood tests done in preparation for several monthly rounds of senolytic treatments with first Fisetin and then D+Q, which we started a few days ago.
The results of the calculations (assuming that I did them correctly) are rather shocking. I just had my 84-year birthday and my wife will turn 79 in a couple of weeks. The calculations say that I have a 97.8% chance of mortality in the next 10 years and that my wife's mortality probability is 72.5%. Further my DNAm PhenoAge is 98.7 years and hers in 86.6 years.
Looking at what goes into producing the above values, the three most important factors are: (1) actual age, (2) red cell distribution width, and (3) mean cell volume. The least important contribution to the calculation is the C-reactive protein, a measure of inflammation. I find this rather surprising and counter-intuitive. I would expect inflammation to play a large role in mortality and blood cell volume and distribution width to be rather minor factors.